BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 16765445)

  • 41. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins.
    Ren B; Chee KJ; Kim TH; Maniatis T
    Genes Dev; 1999 Jan; 13(1):125-37. PubMed ID: 9887105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation and specificity of MHC2TA promoter usage in human primary T lymphocytes and cell line.
    Wong AW; Ghosh N; McKinnon KP; Reed W; Piskurich JF; Wright KL; Ting JP
    J Immunol; 2002 Sep; 169(6):3112-9. PubMed ID: 12218128
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Velásquez LN; Milillo MA; Delpino MV; Trotta A; Fernández P; Pozner RG; Lang R; Balboa L; Giambartolomei GH; Barrionuevo P
    J Leukoc Biol; 2017 Mar; 101(3):759-773. PubMed ID: 27765819
    [No Abstract]   [Full Text] [Related]  

  • 44. Notch1-mediated signaling induces MHC class II expression through activation of class II transactivator promoter III in mast cells.
    Nakano N; Nishiyama C; Yagita H; Koyanagi A; Ogawa H; Okumura K
    J Biol Chem; 2011 Apr; 286(14):12042-8. PubMed ID: 21321116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Not polymorphism but methylation of class II transactivator gene promoter IV associated with persistent HBV infection.
    He Y; Zhao Y; Zhang S; Chen W; Lin S; Yang Q; Liu J; Yang Y; Jin Y; Liu M
    J Clin Virol; 2006 Dec; 37(4):282-6. PubMed ID: 16996793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
    Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
    Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines.
    Tschickardt ME; Lu Y; Jacim M; Ussery GD; Steimle V; Mach B; Blanck G
    Int J Cancer; 1995 Aug; 62(4):461-5. PubMed ID: 7635572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator.
    Pai RK; Askew D; Boom WH; Harding CV
    J Immunol; 2002 Aug; 169(3):1326-33. PubMed ID: 12133955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells.
    Butticè G; Miller J; Wang L; Smith BD
    Circ Res; 2006 Mar; 98(4):472-9. PubMed ID: 16439692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.
    Lin JH; Lin JY; Chou YC; Chen MR; Yeh TH; Lin CW; Lin SJ; Tsai CH
    Blood; 2015 Apr; 125(14):2228-38. PubMed ID: 25631773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ZBTB32 is an early repressor of the CIITA and MHC class II gene expression during B cell differentiation to plasma cells.
    Yoon HS; Scharer CD; Majumder P; Davis CW; Butler R; Zinzow-Kramer W; Skountzou I; Koutsonanos DG; Ahmed R; Boss JM
    J Immunol; 2012 Sep; 189(5):2393-403. PubMed ID: 22851713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development.
    Shi B; Vinyals A; Alia P; Broceño C; Chen F; Adrover M; Gelpi C; Price JE; Fabra A
    Int J Biochem Cell Biol; 2006; 38(4):544-62. PubMed ID: 16343978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells.
    Miura R; Kasakura K; Nakano N; Hara M; Maeda K; Okumura K; Ogawa H; Yashiro T; Nishiyama C
    PLoS One; 2016; 11(4):e0154094. PubMed ID: 27105023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells.
    Rigaud G; De Lerma Barbaro A; Nicolis M; Cestari T; Ramarli D; Riviera AP; Accolla RS
    J Immunol; 1996 Jun; 156(11):4254-8. PubMed ID: 8666795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and characterization of a novel repressor of beta-interferon gene expression.
    Keller AD; Maniatis T
    Genes Dev; 1991 May; 5(5):868-79. PubMed ID: 1851123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma).
    Xu Y; Wang L; Butticè G; Sengupta PK; Smith BD
    J Biol Chem; 2004 Oct; 279(40):41319-32. PubMed ID: 15247294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Common distal elements orchestrate CIITA isoform-specific expression in multiple cell types.
    Lohsen S; Majumder P; Scharer CD; Barwick BG; Austin JW; Zinzow-Kramer WM; Boss JM
    Genes Immun; 2014 Dec; 15(8):543-55. PubMed ID: 25101797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of the sequence polymorphism within class II transactivator gene promoters.
    Janitz M; Reiners-Schramm L; Muhlethaler-Mottet A; Rosowski M; Lauster R
    Exp Clin Immunogenet; 2001; 18(4):199-205. PubMed ID: 11872950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y.
    Tosi G; Pilotti E; Mortara L; De Lerma Barbaro A; Casoli C; Accolla RS
    Proc Natl Acad Sci U S A; 2006 Aug; 103(34):12861-6. PubMed ID: 16908858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.
    Masternak K; Muhlethaler-Mottet A; Villard J; Zufferey M; Steimle V; Reith W
    Genes Dev; 2000 May; 14(9):1156-66. PubMed ID: 10809673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.